Antisense oligonucleotides targeting the progesterone receptor inhibit hormone-independent breast cancer growth in mice
2005

Inhibition of Breast Cancer Growth Using Antisense Oligonucleotides

Sample size: 12 publication 10 minutes Evidence: moderate

Author Information

Author(s): Lamb Caroline A, Helguero Luisa A, Giulianelli Sebastián, Soldati Rocío, Vanzulli Silvia I, Molinolo Alfredo, Lanari Claudia

Primary Institution: Instituto de Biología y Medicina Experimental (CONICET), Buenos Aires, Argentina

Hypothesis

Can antisense oligonucleotides targeting the progesterone receptor inhibit hormone-independent breast cancer growth in mice?

Conclusion

The study demonstrates that antisense oligonucleotides can inhibit tumor growth in vivo, highlighting the role of the progesterone receptor pathway in mammary carcinomas.

Supporting Evidence

  • Antisense oligonucleotides significantly inhibited tumor growth in treated mice.
  • Histological signs of tumor regression were observed in asPR-treated mice.
  • Decreased levels of phosphorylated ERK were noted in tumors treated with asPR.

Takeaway

Scientists found a way to stop some breast cancer tumors from growing by using special molecules that block a hormone's action.

Methodology

The study involved injecting mice with antisense oligonucleotides and measuring tumor growth over time.

Limitations

The study was conducted in mice, which may not fully replicate human responses.

Participant Demographics

Two-month-old virgin female BALB/c mice were used in the experiments.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/bcr1345

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication